1. Home
  2. BSAC vs MRNA Comparison

BSAC vs MRNA Comparison

Compare BSAC & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSAC
  • MRNA
  • Stock Information
  • Founded
  • BSAC 1977
  • MRNA 2010
  • Country
  • BSAC Chile
  • MRNA United States
  • Employees
  • BSAC N/A
  • MRNA N/A
  • Industry
  • BSAC Commercial Banks
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BSAC Finance
  • MRNA Health Care
  • Exchange
  • BSAC Nasdaq
  • MRNA Nasdaq
  • Market Cap
  • BSAC 13.4B
  • MRNA 9.2B
  • IPO Year
  • BSAC 1994
  • MRNA 2018
  • Fundamental
  • Price
  • BSAC $30.19
  • MRNA $26.33
  • Analyst Decision
  • BSAC Hold
  • MRNA Hold
  • Analyst Count
  • BSAC 3
  • MRNA 15
  • Target Price
  • BSAC $26.67
  • MRNA $36.69
  • AVG Volume (30 Days)
  • BSAC 286.0K
  • MRNA 12.0M
  • Earning Date
  • BSAC 10-30-2025
  • MRNA 11-06-2025
  • Dividend Yield
  • BSAC 3.28%
  • MRNA N/A
  • EPS Growth
  • BSAC 42.15
  • MRNA N/A
  • EPS
  • BSAC 0.01
  • MRNA N/A
  • Revenue
  • BSAC $2,434,135,287.00
  • MRNA $2,232,000,000.00
  • Revenue This Year
  • BSAC $41.31
  • MRNA N/A
  • Revenue Next Year
  • BSAC $5.39
  • MRNA $10.38
  • P/E Ratio
  • BSAC $12.55
  • MRNA N/A
  • Revenue Growth
  • BSAC 20.98
  • MRNA N/A
  • 52 Week Low
  • BSAC $18.19
  • MRNA $23.04
  • 52 Week High
  • BSAC $30.22
  • MRNA $48.92
  • Technical
  • Relative Strength Index (RSI)
  • BSAC 77.36
  • MRNA 53.21
  • Support Level
  • BSAC $28.27
  • MRNA $23.04
  • Resistance Level
  • BSAC $30.18
  • MRNA $25.56
  • Average True Range (ATR)
  • BSAC 0.61
  • MRNA 1.58
  • MACD
  • BSAC 0.10
  • MRNA -0.07
  • Stochastic Oscillator
  • BSAC 98.71
  • MRNA 57.39

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: